Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in ENSC — Ensysce Biosciences, Inc.

CIK 1214717 BOSTON, MA
Back to ENSC Full portfolio

Position in ENSC

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$18,033
-$21,787 QoQ
Shares Held
62,188
-15.8% QoQ
Ownership
0.320%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 17 holders
Holding Since
Sep 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ENSC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. ENSC ranks #504 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in ENSC

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,033 62,188
2026-03-31 $39,820 73,880
2025-12-31 $20,322 22,090
2025-09-30 $30,880 13,030
2025-06-30 $22,658 10,161
2024-09-30 $11,057 46,072
2024-06-30 $23,326 46,101
2024-03-31 $14,471 18,318
2023-12-31 $17,257 16,281
2023-09-30 $22,673 16,430
2022-09-30 $28,062 130,523
2022-06-30 $110,538 127,348
2022-03-31 $125,680 110,246
2021-12-31 $474,328 100,921
2021-09-30 $166,437 54,930